The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 305.00
Bid: 296.00
Ask: 304.00
Change: 0.00 (0.00%)
Spread: 8.00 (2.703%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 305.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

11 Nov 2009 07:00

RNS Number : 3034C
Fisher (James) & Sons PLC
11 November 2009
 



James Fisher and Sons plc

11 November 2009

Interim Management Statement

The Board of James Fisher and Sons plc is pleased to announce its Interim Management Statement in respect of the period from 1 July 2009 to date. Trading in the third quarter was in line with management expectations and very similar in pattern to trading in the second quarter. We have continued to see strong performances from the majority of our businesses but there has been no improvement to date in the performance of James Fisher Everard, our coastal tanker business.

The specialist technical division continued to trade strongly, benefiting from robust organic growth. In August we purchased MB Faber Limited for up to £5.25 million to strengthen James Fisher Nuclear, our growing nuclear business.

The offshore division continued to perform in line with the first half with strong performances in Norway and the new southern hemisphere oil provinces, offset by a Scottish sector quieter than last year. The fundamentals of this business remain sound and we shall continue to invest in our niche offshore businesses.

The local refinancing of our Singaporean submarine rescue service joint venture was only completed in late August, some four months later than anticipated. Although the delays on this project have affected the 2009 result, including the second half, we have now received full payment reducing our financial gearing and the through-life service, which is contracted until 2029, will benefit both from the decline in interest rates and sterling against the Singapore dollar. Our world leading submarine rescue activities continue to receive strong interest from countries worldwide which need to protect their submariners.

Trading for James Fisher Everard remains the most affected by the present challenging economic environment and there has been no improvement over the second quarter. The winter season and a strengthening Continental European economy ought to be positive influences, but so far there has been no sign of either improved volumes or a stronger spot market, the two keys to a recovery in earnings for this division.

James Fisher continues to monitor acquisition opportunities to strengthen our marine support divisions. In the current economic climate, these opportunities are becoming more plentiful and less subject to competition and we have the financial resources and proven track record to take advantage of them as they occur.

The overall resilience and strength of the Company and its marine service strategy has been demonstrated by its continued ability to grow profits in the most serious economic downturn of recent times. It remains well placed to produce long-term growth and value for its shareholders.

Contacts

James Fisher and Sons plc

Tim Harris

Chairman

020 7614 9508

Financial Dynamics

Richard Mountain

020 7269 7186

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSCKKKPABDDKDD
Date   Source Headline
30th Mar 20225:48 pmRNSAnnual Report and Notice of 2022 AGM posted
22nd Mar 20224:35 pmRNSHolding(s) in Company
10th Mar 20227:00 amRNSFull year results for the year ended 31 Dec 21
24th Jan 202210:54 amRNSDirector Declaration
29th Dec 20219:55 amRNSMozambique update
17th Dec 20217:00 amRNSAppointment of non-executive director
15th Dec 20215:36 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:22 pmRNSHolding(s) in Company
18th Nov 202110:25 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSale of James Fisher Testing Services for £5.7m
1st Nov 20215:23 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSTrading update
22nd Oct 20218:00 amRNSAppointment of non-executive director
15th Sep 20211:26 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf year results for the 6 months ended 30 Jun 21
1st Jul 20217:00 amRNSSale of Paladin for US$17.3m
29th Jun 20217:00 amRNSCapital Markets Event & Pre Close Trading Update
15th Jun 20213:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jun 20214:16 pmRNSDirector/PDMR Shareholding
30th Apr 202111:59 amRNSDirector Declaration
29th Apr 20212:01 pmRNSResult of Annual General Meeting
29th Apr 20217:00 amRNSAGM Trading Statement
20th Apr 20217:00 amRNSAppointment of Chief Financial Officer
13th Apr 202111:32 amRNSWithdrawal of Annual General Meeting Resolution
9th Apr 202110:18 amRNSDirector/PDMR Shareholding
8th Apr 20213:58 pmRNSDirector/PDMR Shareholding
6th Apr 20213:48 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights and Share Capital
29th Mar 20217:00 amRNSDirectorate Change
23rd Mar 202112:58 pmRNSAnnual Report and Notice of AGM posted
19th Mar 20211:17 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSResults for the year ended 31 December 2020
25th Feb 202110:42 amRNSNotification of FY Results Date
25th Jan 20217:00 amRNSAngus Cockburn appointed as Chairman
7th Jan 20217:00 amRNSPost close trading update
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 202011:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Nov 20207:00 amRNSDirector/PDMR Shareholding
9th Nov 20205:25 pmRNSTotal Voting Rights
6th Nov 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSTotal Voting Rights
23rd Oct 20209:48 amRNSDirector/PDMR Shareholding
6th Oct 20203:58 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSRoyal Navy contract award
21st Sep 20204:00 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSHalf-year results
24th Jul 202012:00 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHalf year post close trading update
24th Jun 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.